"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","41/61","481/2914",4.67287949462896e-19,2.42989733720706e-16,1.39202620734736e-16,"AKT1/AKT2/AKT3/CDK1/CDK2/CDK4/CREB1/CREBBP/CTNNB1/FBXW7/FOXO1/GSK3B/NR1I2/PPARGC1A/SRC/TP53/AR/CASP1/EP300/MAPK1/MAPK3/RB1/SMAD2/SMAD3/SMAD4/UBE2I/TAF1/FOXO4/LEF1/TCF7/TCF7L2/PPARG/MAF/SMAD1/HNF4A/ESRRA/BCL6/RUNX2/VDR/E2F4/STAT1",41
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","19/61","62/2914",1.34564268228732e-18,3.37403306362405e-16,1.93289748381702e-16,"AKT1/AKT2/AKT3/CDK1/CDK4/FBXW7/GSK3B/PPARGC1A/SRC/AR/MAPK1/MAPK3/RB1/SMAD4/MAF/SMAD1/ESRRA/RUNX2/STAT1",19
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","41/61","499/2914",1.94655753670618e-18,3.37403306362405e-16,1.93289748381702e-16,"AKT1/AKT2/AKT3/CDK1/CDK2/CDK4/CREB1/CREBBP/CTNNB1/FBXW7/FOXO1/GSK3B/NR1I2/PPARGC1A/SRC/TP53/AR/CASP1/EP300/MAPK1/MAPK3/RB1/SMAD2/SMAD3/SMAD4/UBE2I/TAF1/FOXO4/LEF1/TCF7/TCF7L2/PPARG/MAF/SMAD1/HNF4A/ESRRA/BCL6/RUNX2/VDR/E2F4/STAT1",41
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","12/61","49/2914",1.17208356065224e-10,1.52370862884791e-08,8.72893809643643e-09,"AKT1/AKT2/AKT3/CREBBP/FOXO1/PPARGC1A/EP300/SMAD2/SMAD3/SMAD4/FOXO4/BCL6",12
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","9/61","24/2914",4.30876611100815e-10,4.48111675544847e-08,2.56711749350591e-08,"SRC/AR/MAPK1/MAPK3/RB1/SMAD4/MAF/SMAD1/RUNX2",9
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","22/61","268/2914",5.6696072782025e-09,4.91365964110883e-07,2.81491028023036e-07,"AKT1/AKT2/AKT3/CREB1/CREBBP/CSNK1A1/CTNNB1/FBXW7/FOXO1/GSK3B/SRC/EP300/MAPK1/MAPK3/SMAD2/SMAD3/SMAD4/STAT3/FOXO4/TCF7L2/STAT5A/STAT1",22
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","8/61","24/2914",1.30541054861962e-08,9.69733550403143e-07,5.55535616931355e-07,"AKT1/AKT2/AKT3/CREBBP/FOXO1/EP300/PAX6/HNF4A",8
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","26/61","397/2914",1.78358357893023e-08,1.15932932630465e-06,6.6415020110165e-07,"AKT1/AKT2/AKT3/CDK2/CDK4/CREB1/CREBBP/CTNNB1/FOXO1/GSK3B/PPARGC1A/SRC/EP300/FLI1/MAPK1/MAPK3/PAX6/SMAD2/SMAD3/SMAD4/STAT3/LEF1/TCF4/PPARG/HNF4A/SREBF2",26
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","6/61","11/2914",2.79432983102347e-08,1.61450168014689e-06,9.24906832958646e-07,"AKT1/AKT2/AKT3/FOXO1/PAX6/HNF4A",6
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","7/61","19/2914",5.13803158986115e-08,2.6717764267278e-06,1.53059256834811e-06,"SRC/AR/MAPK1/MAPK3/RB1/MAF/RUNX2",7
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","10/61","53/2914",7.32864618700621e-08,3.46445092476657e-06,1.98469557026101e-06,"CREBBP/CTNNB1/SRC/TP53/EP300/SMAD3/SMAD4/LEF1/TCF7/TCF7L2",10
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","9/61","47/2914",3.08650356652989e-07,1.30056850276903e-05,7.45062522841367e-06,"CREBBP/PPARGC1A/ARNTL/EP300/NRF1/PPARG/ESRRA/CLOCK/SREBF2",9
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","7/61","24/2914",3.25142125692257e-07,1.30056850276903e-05,7.45062522841367e-06,"AKT1/AKT2/AKT3/CREB1/FOXO1/GSK3B/FOXO4",7
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","9/61","48/2914",3.73725533583639e-07,1.38812341045352e-05,7.95220496271955e-06,"CREBBP/PPARGC1A/ARNTL/EP300/NRF1/PPARG/ESRRA/CLOCK/SREBF2",9
"R-HSA-1643685","R-HSA-1643685","Disease","25/61","443/2914",7.81415673298194e-07,2.58115132201362e-05,1.47867575734788e-05,"AKT1/AKT2/AKT3/CDC25A/CDK4/CREB1/CREBBP/CSNK1A1/CTNNB1/FBXW7/FOXO1/GSK3B/SRC/EP300/MAPK1/MAPK3/SMAD2/SMAD3/SMAD4/STAT3/TAF1/FOXO4/TCF7L2/STAT5A/STAT1",25
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","7/61","27/2914",7.94200406773422e-07,2.58115132201362e-05,1.47867575734788e-05,"CDK2/CDK4/CREB1/EP300/FLI1/STAT3/LEF1",7
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","8/61","39/2914",8.5411236965554e-07,2.612579013064e-05,1.49667987995367e-05,"AKT1/AKT2/AKT3/CDC25A/CDK2/CDK4/RB1/E2F4",8
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","16/61","191/2914",9.18754493276478e-07,2.65417964724316e-05,1.5205118222061e-05,"AKT1/AKT2/AKT3/CDC25A/CDK1/CDK2/CDK4/GSK3B/SRC/TP53/EP300/MAPK1/MAPK3/RB1/FOXM1/E2F4",16
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","8/61","40/2914",1.0502827697431e-06,2.87445810666533e-05,1.64670373317063e-05,"AKT1/AKT2/AKT3/CDC25A/CDK2/CDK4/RB1/E2F4",8
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","5/61","11/2914",1.42954822420035e-06,3.56565673137005e-05,2.04267379550147e-05,"AKT1/AKT2/AKT3/FOXO1/FOXO4",5
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","6/61","19/2914",1.43997675689944e-06,3.56565673137005e-05,2.04267379550147e-05,"FOXO1/PPARGC1A/SMAD2/SMAD3/SMAD4/FOXO4",6
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","7/61","31/2914",2.20242026579717e-06,5.20572062824785e-05,2.98222457043348e-05,"AKT1/AKT2/CTNNB1/LEF1/TCF7/TCF7L2/SOX6",7
"R-HSA-69206","R-HSA-69206","G1/S Transition","9/61","60/2914",2.70771080025249e-06,6.04908640548256e-05,3.46536731326228e-05,"AKT1/AKT2/AKT3/CDC25A/CDK1/CDK2/CDK4/RB1/E2F4",9
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","10/61","77/2914",2.79188603329965e-06,6.04908640548256e-05,3.46536731326228e-05,"AKT1/AKT2/AKT3/CDC25A/CDK1/CDK2/CDK4/SRC/RB1/E2F4",10
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","6/61","22/2914",3.77058975693555e-06,7.71142635786269e-05,4.41767947221689e-05,"CREBBP/CTNNB1/EP300/LEF1/TCF7/TCF7L2",6
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","5/61","13/2914",3.85571317893135e-06,7.71142635786269e-05,4.41767947221689e-05,"CREBBP/FOXO1/EP300/FOXO4/BCL6",5
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","5/61","14/2914",5.90169675094955e-06,0.000109602939660492,6.27887285909294e-05,"AKT1/AKT2/AKT3/TP53/EP300",5
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","5/61","14/2914",5.90169675094955e-06,0.000109602939660492,6.27887285909294e-05,"FOXO1/SMAD2/SMAD3/SMAD4/FOXO4",5
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","6/61","24/2914",6.5832950318849e-06,0.000118045290226902,6.76251358992169e-05,"AKT1/AKT2/AKT3/CREB1/MAPK1/MAPK3",6
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","17/61","249/2914",6.9581234610536e-06,0.000120607473324929,6.90929452448481e-05,"AKT1/AKT2/AKT3/CDC25A/CDK1/CDK2/CDK4/GSK3B/SRC/TP53/EP300/MAPK1/MAPK3/RB1/UBE2I/FOXM1/E2F4",17
"R-HSA-400253","R-HSA-400253","Circadian Clock","8/61","52/2914",8.44138513113854e-06,0.000141597428006195,8.11175549104315e-05,"CREB1/CREBBP/PPARGC1A/ARNTL/BHLHE40/EP300/CLOCK/HIF1A",8
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","11/61","108/2914",9.59961982548092e-06,0.000155993822164065,8.93648819279967e-05,"AKT1/AKT2/CREBBP/CSNK1A1/CTNNB1/GSK3B/EP300/LEF1/TCF7/TCF7L2/SOX6",11
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","6/61","26/2914",1.0899119492675e-05,0.000171743701096696,9.83875858509415e-05,"FBXW7/GSK3B/PPARGC1A/ESRRA/RUNX2/STAT1",6
"R-HSA-69242","R-HSA-69242","S Phase","9/61","71/2914",1.13938927663039e-05,0.000174259536425824,9.98288437419194e-05,"AKT1/AKT2/AKT3/CDC25A/CDK2/CDK4/GSK3B/RB1/E2F4",9
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","6/61","29/2914",2.14127650242575e-05,0.000309295494794831,0.000177187500054529,"AKT1/AKT2/AKT3/CDK1/CDK2/TP53",6
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","6/61","29/2914",2.14127650242575e-05,0.000309295494794831,0.000177187500054529,"AKT1/AKT2/AKT3/CDK1/CDK2/TP53",6
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","11/61","119/2914",2.45411106549445e-05,0.000344902095691113,0.000197585613523451,"CREBBP/PPARGC1A/ARNTL/EP300/UBE2I/NRF1/PPARG/ESRRA/CLOCK/SREBF2/VDR",11
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","9/61","80/2914",3.06155873110628e-05,0.000418950142151385,0.000240005850665672,"CDC25A/TP53/AR/SMAD2/SMAD3/SMAD4/FOXO4/SMAD1/HIF1A",9
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","4/61","10/2914",3.3250674412471e-05,0.000432258767362123,0.00024763002259814,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","4/61","10/2914",3.3250674412471e-05,0.000432258767362123,0.00024763002259814,"CREBBP/FOXO1/EP300/FOXO4",4
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","11/61","124/2914",3.62932362692554e-05,0.00045096018083473,0.000258343585376981,"CDC25A/CDK1/TP53/AR/EP300/SMAD2/SMAD3/SMAD4/FOXO4/SMAD1/HIF1A",11
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","13/61","172/2914",3.64237069135743e-05,0.00045096018083473,0.000258343585376981,"AKT1/AKT2/AKT3/CREB1/FOXO1/GSK3B/PHLPP1/SRC/TP53/MAPK1/MAPK3/FOXO4/PPARG",13
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","7/61","49/2914",5.3554534205738e-05,0.000647636227604274,0.000371014276137671,"AKT1/AKT2/AKT3/TP53/MAPK1/MAPK3/STAT3",7
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","5/61","23/2914",8.57880427508856e-05,0.00101385868705592,0.00058081378226078,"CDK4/TP53/MAPK1/MAPK3/RB1",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","6/61","37/2914",9.19711927616592e-05,0.00106277822746806,0.000608838539217533,"CSNK1A1/CTNNB1/GSK3B/LEF1/TCF7/TCF7L2",6
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","5/61","24/2914",0.00010663139741378,0.00119473328730287,0.000684432227341525,"MAPK1/MAPK3/STAT3/STAT5A/STAT1",5
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/61","13/2914",0.000107985508660068,0.00119473328730287,0.000684432227341525,"AKT1/AKT2/AKT3/GSK3B",4
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","6/61","40/2914",0.000144599892446573,0.00156649883483787,0.000897407227245176,"CDK4/CREBBP/PPARGC1A/EP300/PPARG/SREBF2",6
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/61","59/2914",0.000180515044062913,0.00191566985536153,0.00109743839892169,"AKT1/AKT2/AKT3/TP53/MAPK1/MAPK3/PPARG",7
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","13/61","201/2914",0.000185367975181651,0.00192782694188917,0.00110440288371384,"AKT1/AKT2/AKT3/CREB1/FOXO1/GSK3B/PHLPP1/SRC/TP53/MAPK1/MAPK3/FOXO4/PPARG",13
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","4/61","15/2914",0.000199767495889002,0.00203684505612316,0.00116685658073452,"CDK1/TP53/EP300/E2F4",4
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","5/61","28/2914",0.000231173642389848,0.00231173642389848,0.00132433483393375,"NR1I2/AR/UBE2I/PPARG/VDR",5
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","9/61","104/2914",0.000244652605347252,0.00240036518453908,0.00137510799033312,"AKT1/CREB1/CREBBP/FBXW7/TP53/EP300/SMAD3/HIF1A/STAT1",9
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","7/61","63/2914",0.000274167646998974,0.00264013289702716,0.00151246479728479,"AKT1/AKT2/AKT3/CREB1/SRC/MAPK1/MAPK3",7
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","9/61","107/2914",0.00030391696875606,0.00287339679551184,0.00164609573508067,"CREBBP/NR1I2/PPARGC1A/TP53/AR/EP300/UBE2I/PPARG/VDR",9
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","6/61","46/2914",0.000319986846205711,0.00292403599313128,0.00167510563978978,"NR1I2/AR/PPARG/HNF4A/ESRRA/VDR",6
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","5/61","30/2914",0.000324582063591303,0.00292403599313128,0.00167510563978978,"CDK1/CDK2/TP53/EP300/E2F4",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","9/61","108/2914",0.000326142476156951,0.00292403599313128,0.00167510563978978,"AKT1/AKT2/AKT3/CREB1/CREBBP/SRC/EP300/MAPK1/MAPK3",9
"R-HSA-2990846","R-HSA-2990846","SUMOylation","9/61","109/2914",0.000349701197173565,0.00308211224627549,0.00176566349331167,"CREBBP/NR1I2/PPARGC1A/TP53/AR/EP300/UBE2I/PPARG/VDR",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","12/61","187/2914",0.000368440105647396,0.00319314758227744,0.00182927280523181,"CDK2/CDK4/CREBBP/GSK3B/TP53/AR/EP300/MAPK1/MAPK3/RB1/STAT3/HIF1A",12
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","12/61","189/2914",0.000406780939342739,0.00346764079439712,0.00198652296521131,"CDK2/CDK4/CREBBP/GSK3B/TP53/AR/EP300/MAPK1/MAPK3/RB1/STAT3/HIF1A",12
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","4/61","18/2914",0.000427202689804094,0.00358299030158273,0.002052603755765,"CDC25A/CDK1/CDK2/FOXM1",4
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","5/61","32/2914",0.000444143819692574,0.0036659489879387,0.00210012867122804,"CREB1/CREBBP/PPARGC1A/NRF1/ESRRA",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","12/61","194/2914",0.00051777514733687,0.00413431992934896,0.00236844643725861,"AKT1/AKT2/AKT3/CDK1/CDK2/CREBBP/TP53/CASP1/EP300/TAF1/BCL6/E2F4",12
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","4/61","19/2914",0.000532691221666116,0.00413431992934896,0.00236844643725861,"CREBBP/ARNTL/BHLHE40/CLOCK",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","4/61","19/2914",0.000532691221666116,0.00413431992934896,0.00236844643725861,"CDC25A/CDK1/CDK2/E2F4",4
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/61","19/2914",0.000532691221666116,0.00413431992934896,0.00236844643725861,"AKT1/AKT2/AKT3/SRC",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/61","95/2914",0.000672780028535078,0.00514478845350354,0.00294731808166296,"AKT1/AKT2/AKT3/CDK1/CDK2/TP53/EP300/TAF1",8
"R-HSA-195721","R-HSA-195721","Signaling by WNT","11/61","172/2914",0.000690835608811348,0.00520629734176668,0.00298255495489873,"AKT1/AKT2/CREBBP/CSNK1A1/CTNNB1/GSK3B/EP300/LEF1/TCF7/TCF7L2/SOX6",11
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","18/61","393/2914",0.000744387996585489,0.00552973940320649,0.0031678466621608,"CDC25A/CDK1/CREBBP/FBXW7/NR1I2/PPARGC1A/TP53/AR/EP300/SMAD2/SMAD3/SMAD4/UBE2I/FOXO4/PPARG/SMAD1/HIF1A/VDR",18
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","8/61","97/2914",0.000774036528985231,0.00566899993059606,0.00324762546631313,"AKT1/AKT2/AKT3/CREB1/FOXO1/GSK3B/SRC/FOXO4",8
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","3/61","10/2914",0.000943679742892649,0.00681546480978024,0.00390440595378099,"STAT3/STAT5A/STAT1",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","5/61","38/2914",0.00100526942835009,0.00712188629455867,0.00407994700680183,"CREB1/CREBBP/PPARGC1A/NRF1/ESRRA",5
"R-HSA-109581","R-HSA-109581","Apoptosis","8/61","101/2914",0.00101349920345643,0.00712188629455867,0.00407994700680183,"AKT1/AKT2/AKT3/CTNNB1/TP53/MAPK1/MAPK3/STAT3",8
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","4/61","23/2914",0.00114294836433736,0.00789432745689263,0.00452245884676238,"CDK1/DUSP1/MAPK1/MAPK3",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/61","103/2914",0.00115378632062277,0.00789432745689263,0.00452245884676238,"AKT1/AKT2/AKT3/CTNNB1/TP53/MAPK1/MAPK3/STAT3",8
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","7/61","80/2914",0.00119125852779621,0.00804486278511726,0.00460869669673722,"CDK1/CREB1/CREBBP/PPARGC1A/SMO/NRF1/ESRRA",7
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","5/61","40/2914",0.00127617830134595,0.00830876690031757,0.00475988063317788,"AKT1/CREBBP/FBXW7/EP300/SMAD3",5
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","3/61","11/2914",0.00127827183081809,0.00830876690031757,0.00475988063317788,"AKT1/AKT2/AKT3",3
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/61","11/2914",0.00127827183081809,0.00830876690031757,0.00475988063317788,"SMAD2/SMAD4/STAT3",3
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/61","24/2914",0.00135021175772208,0.00856231846360343,0.0049051338566797,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/61","24/2914",0.00135021175772208,0.00856231846360343,0.0049051338566797,"SMAD2/SMAD3/SMAD4/E2F4",4
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/61","25/2914",0.00158241232854122,0.00991390856435463,0.00567942535164445,"AKT1/AKT2/AKT3/CTNNB1",4
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/61","12/2914",0.00167904725056113,0.0101523787243231,0.00581603882385313,"SMAD2/SMAD3/SMAD4",3
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","3/61","12/2914",0.00167904725056113,0.0101523787243231,0.00581603882385313,"STAT3/STAT5A/STAT1",3
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","3/61","12/2914",0.00167904725056113,0.0101523787243231,0.00581603882385313,"CTNNB1/PAX6/TCF7L2",3
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","9/61","136/2914",0.00176074889325929,0.0105240163735038,0.00602894055405178,"AKT1/AKT2/AKT3/CREB1/CREBBP/SRC/EP300/MAPK1/MAPK3",9
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/61","13/2914",0.00215036577313145,0.0127067068412313,0.00727934825115073,"AKT1/AKT2/AKT3",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/61","45/2914",0.00218687918419783,0.0127772716380098,0.00731977302339428,"CDK2/CDK4/MAPK1/MAPK3/STAT3",5
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/61","66/2914",0.00224137641790248,0.0129501748589921,0.00741882486861289,"CDC25A/CDK1/CDK2/TP53/EP300/FOXM1",6
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","4/61","28/2914",0.00244378289705759,0.0137455482497825,0.00787447399734504,"CREBBP/UBE2I/SREBF2/VDR",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/61","68/2914",0.00261371346329364,0.0137455482497825,0.00787447399734504,"CDC25A/CDK1/CDK2/TP53/EP300/FOXM1",6
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","5/61","47/2914",0.00265903280649928,0.0137455482497825,0.00787447399734504,"AKT1/CDK2/CDK4/STAT3/HIF1A",5
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","5/61","47/2914",0.00265903280649928,0.0137455482497825,0.00787447399734504,"AKT1/CDK2/CDK4/STAT3/HIF1A",5
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"SRC/MAPK1/MAPK3",3
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CTNNB1/PAX6/TCF7L2",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","3/61","14/2914",0.00269624215668811,0.0137455482497825,0.00787447399734504,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","4/61","29/2914",0.00279080834855891,0.0139540417427946,0.00799391460164142,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","4/61","29/2914",0.00279080834855891,0.0139540417427946,0.00799391460164142,"SRC/STAT3/STAT5A/STAT1",4
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/61","70/2914",0.00303088638124069,0.0149700965823395,0.00857598650364796,"CREB1/SRC/MAPK1/MAPK3/STAT3/ATF1",6
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","7/61","94/2914",0.00305159661101537,0.0149700965823395,0.00857598650364796,"AKT1/FOXO1/TP53/STAT3/BCL6/HIF1A/STAT1",7
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","4/61","30/2914",0.00317022777701547,0.0152640596671115,0.00874439045706995,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","4/61","30/2914",0.00317022777701547,0.0152640596671115,0.00874439045706995,"CREBBP/TP53/CASP1/BCL6",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/61","49/2914",0.00320128049219066,0.0152721638159555,0.00874903311723764,"CREBBP/GSK3B/EP300/MAPK1/MAPK3",5
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/61","15/2914",0.00332036082188788,0.0154159609587652,0.00883141083265293,"AKT1/AKT2/AKT3",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/61","15/2914",0.00332036082188788,0.0154159609587652,0.00883141083265293,"SMAD2/SMAD3/SMAD4",3
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","3/61","15/2914",0.00332036082188788,0.0154159609587652,0.00883141083265293,"CASP1/SMAD3/STAT3",3
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","4/61","31/2914",0.00358347277788104,0.0163456653026153,0.00936401473813789,"AKT1/AKT2/AKT3/SRC",4
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","4/61","31/2914",0.00358347277788104,0.0163456653026153,0.00936401473813789,"CSNK1A1/CTNNB1/GSK3B/TCF7L2",4
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","3/61","16/2914",0.00402609003666987,0.0177203404954269,0.010151531093534,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/61","16/2914",0.00402609003666987,0.0177203404954269,0.010151531093534,"AKT1/AKT2/AKT3",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","4/61","32/2914",0.00403194834333653,0.0177203404954269,0.010151531093534,"CREB1/SRC/MAPK1/MAPK3",4
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/61","32/2914",0.00403194834333653,0.0177203404954269,0.010151531093534,"TP53/MAPK1/MAPK3/PPARG",4
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","7/61","99/2914",0.00408930934509851,0.0177203404954269,0.010151531093534,"AKT1/AKT2/AKT3/PHLPP1/SRC/MAPK1/MAPK3",7
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","7/61","99/2914",0.00408930934509851,0.0177203404954269,0.010151531093534,"CDK2/CDK4/TP53/MAPK1/MAPK3/RB1/STAT3",7
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","4/61","33/2914",0.00451703043571942,0.0194120316245793,0.0111206577930282,"CDK1/MAPK1/MAPK3/RB1",4
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/61","17/2914",0.00481649562475261,0.0205293256136997,0.0117607270216134,"CREBBP/EP300/SMAD3",3
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/61","35/2914",0.00560235973695039,0.0236847728716602,0.0135684022726312,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/61","18/2914",0.00569435421174231,0.023688513520848,0.0135705451951417,"CREB1/MAPK1/MAPK3",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/61","18/2914",0.00569435421174231,0.023688513520848,0.0135705451951417,"CREBBP/EP300/STAT1",3
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/61","36/2914",0.00620519463500778,0.0256087397635242,0.0146705938321404,"SMAD2/SMAD3/SMAD4/E2F4",4
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/61","37/2914",0.00684980790713611,0.0280464575725258,0.0160671001883093,"CREBBP/PPARGC1A/EP300/UBE2I",4
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","14/61","332/2914",0.00710531027074473,0.0288653229749005,0.0165362072912891,"AKT1/CREB1/FOXO1/TP53/CASP1/MAPK1/MAPK3/SMAD3/STAT3/BCL6/HIF1A/STAT5A/ATF1/STAT1",14
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/61","20/2914",0.00772216724210912,0.0311281160147034,0.0178325037088281,"SMAD2/SMAD3/SMAD4",3
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/61","21/2914",0.0088763419557493,0.0348443505197898,0.0199614396702439,"AKT1/AKT2/AKT3",3
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","3/61","21/2914",0.0088763419557493,0.0348443505197898,0.0199614396702439,"AKT1/AKT2/AKT3",3
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","4/61","40/2914",0.0090461294618685,0.0348443505197898,0.0199614396702439,"CREBBP/FBXW7/EP300/HIF1A",4
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","4/61","40/2914",0.0090461294618685,0.0348443505197898,0.0199614396702439,"CTNNB1/LEF1/TCF7/TCF7L2",4
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/61","40/2914",0.0090461294618685,0.0348443505197898,0.0199614396702439,"CDK4/SRC/RB1/E2F4",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/61","40/2914",0.0090461294618685,0.0348443505197898,0.0199614396702439,"CDK4/SRC/RB1/E2F4",4
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","4/61","41/2914",0.00986946457891761,0.0374615616748903,0.0214607731862226,"SRC/STAT3/STAT5A/STAT1",4
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/61","89/2914",0.00986968067203841,0.0374615616748903,0.0214607731862226,"CREB1/SRC/MAPK1/MAPK3/STAT3/ATF1",6
"R-HSA-1500620","R-HSA-1500620","Meiosis","3/61","22/2914",0.0101264336758099,0.0378830612332455,0.0217022395324058,"CDK2/CDK4/UBE2I",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/61","22/2914",0.0101264336758099,0.0378830612332455,0.0217022395324058,"CREB1/MAPK1/MAPK3",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/61","23/2914",0.0114739564725307,0.042617552612257,0.0244145088851594,"CREBBP/TP53/EP300",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","4/61","44/2914",0.0126276474448204,0.0450906508261864,0.0258312837728962,"AKT1/AKT2/AKT3/SRC",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","4/61","44/2914",0.0126276474448204,0.0450906508261864,0.0258312837728962,"CDK4/TP53/MAPK1/MAPK3",4
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"CREBBP/EP300/HIF1A",3
"R-HSA-1474165","R-HSA-1474165","Reproduction","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"CDK2/CDK4/UBE2I",3
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"STAT3/STAT5A/STAT1",3
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"CDK2/TP53/RB1",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"CDC25A/CDK2/TP53",3
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"STAT3/STAT5A/STAT1",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/61","24/2914",0.0129202057175034,0.0450906508261864,0.0258312837728962,"AKT1/AKT2/AKT3",3
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","3/61","25/2914",0.0144662684523619,0.0491664025831907,0.0281661779980627,"SRC/MAPK1/MAPK3",3
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/61","25/2914",0.0144662684523619,0.0491664025831907,0.0281661779980627,"CREBBP/EP300/UBE2I",3
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/61","25/2914",0.0144662684523619,0.0491664025831907,0.0281661779980627,"AKT1/AKT2/AKT3",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/61","25/2914",0.0144662684523619,0.0491664025831907,0.0281661779980627,"AKT1/AKT2/AKT3",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","12/61","289/2914",0.0145999587134732,0.0492985618896496,0.0282418886938681,"AKT1/CREBBP/PPARGC1A/ARNTL/EP300/UBE2I/NRF1/PPARG/ESRRA/CLOCK/SREBF2/VDR",12
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","4/61","47/2914",0.0158375189368901,0.0531323215947279,0.030438151844753,"CREB1/SRC/MAPK1/MAPK3",4
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"CDK1/MAPK3",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"MAPK1/MAPK3",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"CDK1/E2F4",2
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"MAPK1/MAPK3",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"GSK3B/EP300",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"MAPK1/MAPK3",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"STAT3/STAT1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/61","10/2914",0.0174124157316294,0.0555488109229896,0.0318224969457613,"MAPK1/MAPK3",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/61","27/2914",0.0178612005853705,0.0559507488216426,0.0320527569160422,"CREBBP/EP300/PAX6",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/61","27/2914",0.0178612005853705,0.0559507488216426,0.0320527569160422,"CREBBP/EP300/PAX6",3
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","3/61","27/2914",0.0178612005853705,0.0559507488216426,0.0320527569160422,"SRC/MAPK1/MAPK3",3
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","4/61","49/2914",0.0182393411088119,0.0564551034320367,0.0323416888082316,"SRC/STAT3/STAT5A/STAT1",4
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","4/61","49/2914",0.0182393411088119,0.0564551034320367,0.0323416888082316,"CREB1/SRC/MAPK1/MAPK3",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/61","28/2914",0.0197112907079681,0.0602933598126082,0.034540527989814,"SMAD2/SMAD3/SMAD4",3
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/61","28/2914",0.0197112907079681,0.0602933598126082,0.034540527989814,"SRC/MAPK1/MAPK3",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"STAT3/STAT1",2
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"CDK1/RB1",2
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"CDC25A/E2F4",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"CREB1/EP300",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"STAT3/STAT5A",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"CREBBP/EP300",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"TP53/CASP1",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"CDK2/TP53",2
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"CDK4/GSK3B",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/61","11/2914",0.0209977810429209,0.0606602563462158,0.0347507136558281,"STAT3/STAT1",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/61","29/2914",0.0216636540571306,0.0622381221530825,0.0356546327314217,"CREBBP/TP53/EP300",3
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","4/61","53/2914",0.0236962097360796,0.0666681577495684,0.0381924871318377,"AKT1/AKT2/AKT3/SRC",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/61","30/2914",0.0237184791993657,0.0666681577495684,0.0381924871318377,"FBXW7/TP53/STAT3",3
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","3/61","30/2914",0.0237184791993657,0.0666681577495684,0.0381924871318377,"CSNK1A1/CTNNB1/GSK3B",3
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","3/61","30/2914",0.0237184791993657,0.0666681577495684,0.0381924871318377,"SRC/MAPK1/MAPK3",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/61","12/2914",0.0248615278013928,0.0680420760880224,0.0389795699046768,"MAPK1/MAPK3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/61","12/2914",0.0248615278013928,0.0680420760880224,0.0389795699046768,"MAPK1/MAPK3",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/61","12/2914",0.0248615278013928,0.0680420760880224,0.0389795699046768,"MAPK1/MAPK3",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/61","12/2914",0.0248615278013928,0.0680420760880224,0.0389795699046768,"CREBBP/EP300",2
"R-HSA-5635838","R-HSA-5635838","Activation of SMO","2/61","12/2914",0.0248615278013928,0.0680420760880224,0.0389795699046768,"CSNK1A1/SMO",2
"R-HSA-391251","R-HSA-391251","Protein folding","3/61","31/2914",0.0258758013159533,0.0700802952307068,0.0401472136645547,"FBXW7/TP53/STAT3",3
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","3/61","31/2914",0.0258758013159533,0.0700802952307068,0.0401472136645547,"STAT3/STAT5A/STAT1",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/61","32/2914",0.028135510244155,0.0731807358929209,0.0419233770398717,"GSK3B/MAPK1/MAPK3",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","3/61","32/2914",0.028135510244155,0.0731807358929209,0.0419233770398717,"SRC/MAPK1/MAPK3",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/61","32/2914",0.028135510244155,0.0731807358929209,0.0419233770398717,"SRC/MAPK1/MAPK3",3
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CREBBP/EP300",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"MAPK1/MAPK3",2
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CSNK1A1/GSK3B",2
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CSNK1A1/GSK3B",2
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CSNK1A1/GSK3B",2
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CSNK1A1/GSK3B",2
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CSNK1A1/GSK3B",2
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CSNK1A1/GSK3B",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"TP53/EP300",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CREBBP/EP300",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/61","13/2914",0.0289908299883494,0.0731807358929209,0.0419233770398717,"CDK2/CDK4",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/61","33/2914",0.0304973582249986,0.076611721144924,0.0438889009797844,"SRC/MAPK1/MAPK3",3
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","5/61","85/2914",0.0310346012160184,0.077586503040046,0.0444473286646417,"AKT1/AKT2/AKT3/CTNNB1/SRC",5
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/61","86/2914",0.0324328523571849,0.0803430364476188,0.0460264763454982,"SMAD2/SMAD3/SMAD4/SMAD1/E2F4",5
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","3/61","34/2914",0.0329609673666206,0.0803430364476188,0.0460264763454982,"CREBBP/CTNNB1/EP300",3
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","3/61","34/2914",0.0329609673666206,0.0803430364476188,0.0460264763454982,"CREBBP/EP300/CLOCK",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/61","34/2914",0.0329609673666206,0.0803430364476188,0.0460264763454982,"SRC/MAPK1/MAPK3",3
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/61","34/2914",0.0329609673666206,0.0803430364476188,0.0460264763454982,"DUSP1/MAPK1/MAPK3",3
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/61","14/2914",0.0333732612936263,0.0803430364476188,0.0460264763454982,"CREBBP/SREBF2",2
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","2/61","14/2914",0.0333732612936263,0.0803430364476188,0.0460264763454982,"STAT3/STAT5A",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/61","14/2914",0.0333732612936263,0.0803430364476188,0.0460264763454982,"CREBBP/EP300",2
"R-HSA-450294","R-HSA-450294","MAP kinase activation","4/61","60/2914",0.0354250519443394,0.084740528222886,0.0485456872208031,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","3/61","35/2914",0.0355258368319022,0.084740528222886,0.0485456872208031,"CSNK1A1/GSK3B/SMO",3
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/61","15/2914",0.0379967844431245,0.0886023673113217,0.0507580363342187,"GSK3B/EP300",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/61","15/2914",0.0379967844431245,0.0886023673113217,0.0507580363342187,"CREBBP/TP53",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/61","15/2914",0.0379967844431245,0.0886023673113217,0.0507580363342187,"CDK1/E2F4",2
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","2/61","15/2914",0.0379967844431245,0.0886023673113217,0.0507580363342187,"CTNNB1/SRC",2
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","2/61","15/2914",0.0379967844431245,0.0886023673113217,0.0507580363342187,"AKT1/FBXW7",2
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","4/61","62/2914",0.0392985598463528,0.0912287996433191,0.0522626524272456,"CDC25A/CDK1/CDK2/TP53",4
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/61","37/2914",0.0409567799222829,0.094236838759235,0.0539858813134889,"SRC/MAPK1/MAPK3",3
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/61","37/2914",0.0409567799222829,0.094236838759235,0.0539858813134889,"CREBBP/EP300/STAT1",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","4/61","63/2914",0.0413232816762167,0.0946612619895714,0.0542290225567787,"SMAD2/SMAD3/SMAD4/E2F4",4
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","5/61","92/2914",0.0416533020630819,0.0949987590912395,0.0544223660380987,"AKT1/AKT2/AKT3/CTNNB1/SRC",5
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/61","16/2914",0.0428497407869038,0.0952216461931195,0.0545500523737911,"MAPK1/MAPK3",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","2/61","16/2914",0.0428497407869038,0.0952216461931195,0.0545500523737911,"CDC25A/CDK2",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/61","16/2914",0.0428497407869038,0.0952216461931195,0.0545500523737911,"TP53/UBE2I",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/61","16/2914",0.0428497407869038,0.0952216461931195,0.0545500523737911,"MAPK1/MAPK3",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/61","16/2914",0.0428497407869038,0.0952216461931195,0.0545500523737911,"CDK1/TP53",2
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","2/61","16/2914",0.0428497407869038,0.0952216461931195,0.0545500523737911,"SRC/EP300",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","4/61","64/2914",0.0434067353529168,0.0956419592521896,0.0547908390047969,"CREBBP/FBXW7/EP300/HIF1A",4
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","4/61","64/2914",0.0434067353529168,0.0956419592521896,0.0547908390047969,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/61","38/2914",0.0438212981439632,0.096147995927683,0.0550807345091787,"SRC/MAPK1/MAPK3",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","12/61","347/2914",0.0521632224427446,0.113970065841291,0.0652905437916706,"AKT1/AKT2/AKT3/CREB1/CTNNB1/SRC/MAPK1/MAPK3/STAT3/STAT5A/ATF1/STAT1",12
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/61","41/2914",0.0529996729609602,0.114786549623333,0.0657582865251077,"STAT3/STAT5A/STAT1",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","3/61","41/2914",0.0529996729609602,0.114786549623333,0.0657582865251077,"SRC/MAPK1/MAPK3",3
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","2/61","18/2914",0.0531991508831216,0.114786549623333,0.0657582865251077,"CSNK1A1/GSK3B",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","3/61","42/2914",0.0562504035453252,0.118903292047029,0.0681166632577109,"CTNNB1/PAX6/TCF7L2",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/61","42/2914",0.0562504035453252,0.118903292047029,0.0681166632577109,"SRC/MAPK1/MAPK3",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/61","42/2914",0.0562504035453252,0.118903292047029,0.0681166632577109,"SRC/MAPK1/MAPK3",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/61","42/2914",0.0562504035453252,0.118903292047029,0.0681166632577109,"SRC/MAPK1/MAPK3",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/61","42/2914",0.0562504035453252,0.118903292047029,0.0681166632577109,"SRC/MAPK1/MAPK3",3
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/61","19/2914",0.0586740902785028,0.122532236726191,0.0701955931042751,"CREBBP/EP300",2
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","2/61","19/2914",0.0586740902785028,0.122532236726191,0.0701955931042751,"CSNK1A1/GSK3B",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/61","19/2914",0.0586740902785028,0.122532236726191,0.0701955931042751,"CREBBP/EP300",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/61","20/2914",0.0643354150603243,0.132755618378447,0.0760523076945354,"CREBBP/SREBF2",2
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/61","20/2914",0.0643354150603243,0.132755618378447,0.0760523076945354,"SRC/MAPK1",2
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","2/61","20/2914",0.0643354150603243,0.132755618378447,0.0760523076945354,"MAPK1/MAPK3",2
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","3/61","45/2914",0.0665588632396885,0.13680082563098,0.0783697037521607,"STAT3/STAT5A/STAT1",3
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","2/61","21/2914",0.0701732122292269,0.143103614544515,0.0819804107613312,"MAPK1/MAPK3",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/61","46/2914",0.07017581097856,0.143103614544515,0.0819804107613312,"SRC/MAPK1/MAPK3",3
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","4/61","76/2914",0.0729568831180608,0.148193668833561,0.0848963730362303,"CTNNB1/LEF1/TCF7/TCF7L2",4
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","4/61","77/2914",0.0757916936976794,0.150617881536029,0.0862851426613285,"CREB1/SRC/MAPK1/MAPK3",4
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/61","22/2914",0.0761778900845686,0.150617881536029,0.0862851426613285,"STAT3/STAT5A",2
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","2/61","22/2914",0.0761778900845686,0.150617881536029,0.0862851426613285,"CDK2/CDK4",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/61","22/2914",0.0761778900845686,0.150617881536029,0.0862851426613285,"SMAD2/SMAD3",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/61","22/2914",0.0761778900845686,0.150617881536029,0.0862851426613285,"CTNNB1/TCF4",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/61","22/2914",0.0761778900845686,0.150617881536029,0.0862851426613285,"CDK2/TP53",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/61","22/2914",0.0761778900845686,0.150617881536029,0.0862851426613285,"CDK2/TP53",2
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","4/61","78/2914",0.0786821639921147,0.153814756676314,0.0881165508894676,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","4/61","78/2914",0.0786821639921147,0.153814756676314,0.0881165508894676,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","4/61","78/2914",0.0786821639921147,0.153814756676314,0.0881165508894676,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/61","49/2914",0.0815479980975262,0.158820071201175,0.0909839679148429,"SRC/MAPK1/MAPK3",3
"R-HSA-201451","R-HSA-201451","Signaling by BMP","2/61","23/2914",0.0823401694761913,0.159170587835017,0.0911847699540682,"SMAD4/SMAD1",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/61","23/2914",0.0823401694761913,0.159170587835017,0.0911847699540682,"STAT3/STAT1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/61","50/2914",0.0855071693165819,0.164680474239343,0.0943412433395426,"SRC/MAPK1/MAPK3",3
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","3/61","51/2914",0.089547786475229,0.169326723516797,0.0970029610430232,"CREBBP/FBXW7/EP300",3
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","3/61","51/2914",0.089547786475229,0.169326723516797,0.0970029610430232,"CREBBP/FBXW7/EP300",3
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","3/61","51/2914",0.089547786475229,0.169326723516797,0.0970029610430232,"CREBBP/FBXW7/EP300",3
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","3/61","51/2914",0.089547786475229,0.169326723516797,0.0970029610430232,"CREBBP/FBXW7/EP300",3
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","3/61","51/2914",0.089547786475229,0.169326723516797,0.0970029610430232,"CREBBP/FBXW7/EP300",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/61","52/2914",0.0936681289704728,0.175738292607344,0.100675985441049,"AKT2/MAPK1/MAPK3",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/61","52/2914",0.0936681289704728,0.175738292607344,0.100675985441049,"AKT2/MAPK1/MAPK3",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","4/61","83/2914",0.0939523948939261,0.175738292607344,0.100675985441049,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","2/61","25/2914",0.0951019280393986,0.175989333026645,0.100819800094212,"AKT1/SRC",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/61","25/2914",0.0951019280393986,0.175989333026645,0.100819800094212,"MAPK1/MAPK3",2
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","2/61","25/2914",0.0951019280393986,0.175989333026645,0.100819800094212,"AKT1/SRC",2
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","4/61","84/2914",0.0971662525570216,0.17853869727792,0.102280265849496,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","4/61","84/2914",0.0971662525570216,0.17853869727792,0.102280265849496,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/61","53/2914",0.0978664441245364,0.179192080791405,0.102654572599124,"SRC/MAPK1/MAPK3",3
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/61","26/2914",0.101684335926537,0.184880610775522,0.105913386334965,"CREB1/MAPK1",2
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/61","26/2914",0.101684335926537,0.184880610775522,0.105913386334965,"AKT1/AKT2",2
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","4/61","86/2914",0.103749045349261,0.186032770971088,0.106573429523923,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","4/61","86/2914",0.103749045349261,0.186032770971088,0.106573429523923,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","4/61","86/2914",0.103749045349261,0.186032770971088,0.106573429523923,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/61","86/2914",0.103749045349261,0.186032770971088,0.106573429523923,"CREBBP/SRC/EP300/RUNX2",4
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/61","55/2914",0.106489841121113,0.188815872806052,0.108167797579176,"SRC/MAPK1/MAPK3",3
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","3/61","55/2914",0.106489841121113,0.188815872806052,0.108167797579176,"CSNK1A1/GSK3B/SMO",3
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","4/61","87/2914",0.107116697072664,0.188815872806052,0.108167797579176,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","4/61","87/2914",0.107116697072664,0.188815872806052,0.108167797579176,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","4/61","87/2914",0.107116697072664,0.188815872806052,0.108167797579176,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/61","27/2914",0.10839018675383,0.189137238630845,0.108351899863419,"SRC/STAT5A",2
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/61","27/2914",0.10839018675383,0.189137238630845,0.108351899863419,"AKT1/AKT2",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/61","27/2914",0.10839018675383,0.189137238630845,0.108351899863419,"CDK1/TP53",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","4/61","88/2914",0.11053429602841,0.192233558310278,0.110125702432811,"CREB1/SRC/MAPK1/MAPK3",4
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/61","56/2914",0.110911286430167,0.19224622981229,0.110132961613113,"CDK2/TP53/TAF1",3
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/61","28/2914",0.11521164029582,0.199036720776831,0.114023060687942,"CREBBP/EP300",2
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","4/61","90/2914",0.11751655142717,0.201678570106034,0.115536508785441,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","4/61","90/2914",0.11751655142717,0.201678570106034,0.115536508785441,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/61","29/2914",0.122141120757945,0.208925601296485,0.119688148111144,"CREB1/EP300",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/61","92/2914",0.124690064787922,0.212586339966293,0.12178529192401,"AKT1/SRC/MAPK1/MAPK3",4
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/61","30/2914",0.129171309440701,0.219506800356746,0.125749847167933,"MAPK1/MAPK3",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","5/61","130/2914",0.133721115860718,0.226498306995353,0.129755102995314,"CTNNB1/SRC/AR/MAPK1/MAPK3",5
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/61","62/2914",0.13885901948035,0.234437305616176,0.134303152812506,"SRC/MAPK1/MAPK3",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/61","32/2914",0.143505779410107,0.241498399007299,0.138348273115518,"STAT3/STAT1",2
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","2/61","33/2914",0.150796645293017,0.252135869943308,0.144442208894648,"CSNK1A1/SMO",2
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","2/61","33/2914",0.150796645293017,0.252135869943308,0.144442208894648,"AKT1/SRC",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/61","34/2914",0.158161375163417,0.259444527081945,0.148629152154232,"CREB1/MAPK1",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/61","34/2914",0.158161375163417,0.259444527081945,0.148629152154232,"CREB1/MAPK1",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/61","34/2914",0.158161375163417,0.259444527081945,0.148629152154232,"MAPK3/STAT1",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/61","34/2914",0.158161375163417,0.259444527081945,0.148629152154232,"CDK1/CDK2",2
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/61","34/2914",0.158161375163417,0.259444527081945,0.148629152154232,"CDK1/FOXO1",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/61","34/2914",0.158161375163417,0.259444527081945,0.148629152154232,"TP53/UBE2I",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/61","35/2914",0.165593832031993,0.269933519299801,0.154638028262841,"MAPK3/STAT1",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/61","35/2914",0.165593832031993,0.269933519299801,0.154638028262841,"TP53/UBE2I",2
"R-HSA-112316","R-HSA-112316","Neuronal System","4/61","105/2914",0.175543910900977,0.284370198344262,0.162908433464425,"CREB1/SRC/MAPK1/MAPK3",4
"R-HSA-68886","R-HSA-68886","M Phase","4/61","105/2914",0.175543910900977,0.284370198344262,0.162908433464425,"CDK1/MAPK1/MAPK3/RB1",4
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/61","37/2914",0.180638456596422,0.291714277733352,0.167115669227811,"GSK3B/EP300",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","3/61","72/2914",0.189981948336666,0.301796140835955,0.172891311450557,"CREBBP/SRC/EP300",3
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/61","10/2914",0.190944096798133,0.301796140835955,0.172891311450557,"RB1",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/61","10/2914",0.190944096798133,0.301796140835955,0.172891311450557,"UBE2I",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/61","10/2914",0.190944096798133,0.301796140835955,0.172891311450557,"SRC",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/61","10/2914",0.190944096798133,0.301796140835955,0.172891311450557,"CREB1",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/61","10/2914",0.190944096798133,0.301796140835955,0.172891311450557,"UBE2I",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/61","10/2914",0.190944096798133,0.301796140835955,0.172891311450557,"SRC",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","4/61","109/2914",0.192482297284077,0.302389107515771,0.173231006937172,"CDK4/CREBBP/EP300/CLOCK",4
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","4/61","109/2914",0.192482297284077,0.302389107515771,0.173231006937172,"CDK4/CREBBP/EP300/CLOCK",4
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","4/61","110/2914",0.196798497007728,0.30823860977114,0.176582037581443,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","6/61","188/2914",0.197393423347544,0.308241982404573,0.176583969677114,"AKT2/SRC/DUSP1/MAPK1/MAPK3/STAT5A",6
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/61","40/2914",0.203572062289753,0.315992454897527,0.181024017684211,"CDK1/CDK2",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/61","40/2914",0.203572062289753,0.315992454897527,0.181024017684211,"CDK1/CDK2",2
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"SRC",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"TP53",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"SRC",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"CDC25A",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"CDC25A",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"CDC25A",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/61","11/2914",0.207938728373655,0.316164148404388,0.181122376515064,"CDK1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","2/61","41/2914",0.211293723280973,0.320328676694187,0.183508128551528,"CREB1/PPARG",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/61","114/2914",0.214362255689772,0.324035967903144,0.1856319411267,"CDC25A/CDK1/CDK2/TP53",4
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/61","42/2914",0.219045889267755,0.328965344582557,0.188455855297295,"CDK1/SMO",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CREB1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"RUNX2",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CDK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CREB1",1
"R-HSA-5620920","R-HSA-5620920","Cargo trafficking to the periciliary membrane","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"SMO",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CDK2",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CASP1",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"STAT5A",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/61","12/2914",0.224582110243861,0.328965344582557,0.188455855297295,"CREB1",1
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/61","43/2914",0.226823994120959,0.331315946468816,0.18980245516331,"MAPK1/MAPK3",2
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/61","44/2914",0.234623643541518,0.341748724486245,0.195779127590298,"SRC/STAT5A",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","3/61","81/2914",0.239504565011263,0.343173478003324,0.196595332540366,"CDK2/TP53/UBE2I",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"CREB1",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"SRC",1
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"SRC",1
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"SRC",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"UBE2I",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/61","13/2914",0.240881383598487,0.343173478003324,0.196595332540366,"EP300",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","3/61","82/2914",0.245151913701127,0.34758512809384,0.199122654353354,"CASP1/SMAD3/STAT3",3
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","6/61","202/2914",0.245314888481614,0.34758512809384,0.199122654353354,"CDK1/FOXO1/SRC/DUSP1/MAPK1/MAPK3",6
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/61","46/2914",0.250270828207577,0.353643561597663,0.202593376380847,"CDK1/TP53",2
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/61","14/2914",0.256843546852707,0.359996345993012,0.206232724526361,"CDK4",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/61","14/2914",0.256843546852707,0.359996345993012,0.206232724526361,"STAT1",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/61","14/2914",0.256843546852707,0.359996345993012,0.206232724526361,"SRC",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","2/61","48/2914",0.265955538914531,0.371765807084829,0.212975148593131,"CDK2/UBE2I",2
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"STAT5A",1
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"SRC",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"CDK1",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"AR",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"CDC25A",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/61","15/2914",0.272475458453391,0.373844956189349,0.214166240084182,"CDC25A",1
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/61","49/2914",0.273802668311,0.374152277701478,0.214342296739915,"CREBBP/EP300",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","4/61","127/2914",0.274138495777429,0.374152277701478,0.214342296739915,"CREB1/MAPK1/MAPK3/ATF1",4
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/61","16/2914",0.287783839631157,0.388695056125199,0.222673483569699,"SRC",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/61","16/2914",0.287783839631157,0.388695056125199,0.222673483569699,"SRC",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/61","16/2914",0.287783839631157,0.388695056125199,0.222673483569699,"CASP1",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/61","16/2914",0.287783839631157,0.388695056125199,0.222673483569699,"SRC",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","2/61","51/2914",0.289489151964769,0.389985386066528,0.223412680681837,"FBXW7/HIF1A",2
"R-HSA-167161","R-HSA-167161","HIV Transcription Initiation","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"TAF1",1
"R-HSA-167162","R-HSA-167162","RNA Polymerase II HIV Promoter Escape","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"TAF1",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"CDK1",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"SRC",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"UBE2I",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"SRC",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"UBE2I",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"CDK2",1
"R-HSA-73776","R-HSA-73776","RNA Polymerase II Promoter Escape","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"TAF1",1
"R-HSA-73779","R-HSA-73779","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"TAF1",1
"R-HSA-75953","R-HSA-75953","RNA Polymerase II Transcription Initiation","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"TAF1",1
"R-HSA-76042","R-HSA-76042","RNA Polymerase II Transcription Initiation And Promoter Clearance","1/61","17/2914",0.302775277099238,0.395585789174884,0.226621008778324,"TAF1",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","5/61","177/2914",0.311149488922022,0.405508105863287,0.232305250929778,"CDK1/SRC/DUSP1/MAPK1/MAPK3",5
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/61","18/2914",0.317456225700186,0.411663933576301,0.235831767615573,"HIF1A",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/61","18/2914",0.317456225700186,0.411663933576301,0.235831767615573,"EP300",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/61","55/2914",0.320742589232743,0.414890911445339,0.237680420929212,"EP300/UBE2I",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/61","19/2914",0.331833011001391,0.425007797341682,0.243476126817199,"CDK1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/61","19/2914",0.331833011001391,0.425007797341682,0.243476126817199,"CTNNB1",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/61","19/2914",0.331833011001391,0.425007797341682,0.243476126817199,"SRC",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/61","19/2914",0.331833011001391,0.425007797341682,0.243476126817199,"EP300",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","2/61","57/2914",0.336263598300331,0.429624253356688,0.246120776720532,"CTNNB1/SRC",2
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/61","20/2914",0.345911831840394,0.437650006221423,0.250718525831301,"SRC",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/61","20/2914",0.345911831840394,0.437650006221423,0.250718525831301,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/61","20/2914",0.345911831840394,0.437650006221423,0.250718525831301,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/61","20/2914",0.345911831840394,0.437650006221423,0.250718525831301,"EP300",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/61","59/2914",0.351686680657389,0.442801631820441,0.25366976073924,"CREB1/MAPK1",2
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","2/61","59/2914",0.351686680657389,0.442801631820441,0.25366976073924,"CDK2/UBE2I",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","4/61","144/2914",0.355939168128845,0.447073351272945,0.256116919858792,"AKT1/AKT2/AKT3/SRC",4
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/61","21/2914",0.359698762820953,0.448545219824689,0.2569601158105,"CTNNB1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/61","21/2914",0.359698762820953,0.448545219824689,0.2569601158105,"SRC",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/61","21/2914",0.359698762820953,0.448545219824689,0.2569601158105,"UBE2I",1
"R-HSA-167172","R-HSA-167172","Transcription of the HIV genome","1/61","22/2914",0.373199756760781,0.461589876588853,0.264433066952723,"TAF1",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/61","22/2914",0.373199756760781,0.461589876588853,0.264433066952723,"CREB1",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/61","22/2914",0.373199756760781,0.461589876588853,0.264433066952723,"EP300",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","2/61","62/2914",0.374597938308646,0.461589876588853,0.264433066952723,"SRC/STAT3",2
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/61","62/2914",0.374597938308646,0.461589876588853,0.264433066952723,"CDK2/TP53",2
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","2/61","63/2914",0.382167188536124,0.469803636025495,0.269138520233229,"CDK2/UBE2I",2
"R-HSA-392518","R-HSA-392518","Signal amplification","1/61","23/2914",0.386420647091898,0.47168717485396,0.270217551586378,"SRC",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/61","23/2914",0.386420647091898,0.47168717485396,0.270217551586378,"UBE2I",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/61","23/2914",0.386420647091898,0.47168717485396,0.270217551586378,"CDK2",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/61","24/2914",0.399367150214484,0.48329557089473,0.27686770559354,"AR",1
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","1/61","24/2914",0.399367150214484,0.48329557089473,0.27686770559354,"STAT5A",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/61","24/2914",0.399367150214484,0.48329557089473,0.27686770559354,"STAT1",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/61","153/2914",0.399648260547565,0.48329557089473,0.27686770559354,"AKT1/SRC/MAPK1/MAPK3",4
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","2/61","66/2914",0.404645475698929,0.48820335815184,0.279679251734758,"CREBBP/EP300",2
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/61","25/2914",0.412044867805112,0.491429658850134,0.28152751711455,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/61","25/2914",0.412044867805112,0.491429658850134,0.28152751711455,"CREB1",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/61","25/2914",0.412044867805112,0.491429658850134,0.28152751711455,"CDK1",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/61","25/2914",0.412044867805112,0.491429658850134,0.28152751711455,"CDK1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/61","25/2914",0.412044867805112,0.491429658850134,0.28152751711455,"SRC",1
"R-HSA-73894","R-HSA-73894","DNA Repair","4/61","157/2914",0.418971432576479,0.498547242425101,0.285604999203044,"CDK2/TP53/EP300/UBE2I",4
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/61","26/2914",0.424459289080255,0.499363869506183,0.286072824028845,"CREBBP",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/61","26/2914",0.424459289080255,0.499363869506183,0.286072824028845,"CDK1",1
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/61","26/2914",0.424459289080255,0.499363869506183,0.286072824028845,"TAF1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/61","26/2914",0.424459289080255,0.499363869506183,0.286072824028845,"CTNNB1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/61","26/2914",0.424459289080255,0.499363869506183,0.286072824028845,"CDK1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","4/61","160/2914",0.433385269556104,0.506786188322011,0.290324881164229,"AKT1/AKT2/AKT3/SRC",4
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/61","27/2914",0.436615793015887,0.506786188322011,0.290324881164229,"CDK1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/61","27/2914",0.436615793015887,0.506786188322011,0.290324881164229,"CDK1",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/61","27/2914",0.436615793015887,0.506786188322011,0.290324881164229,"CDK1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/61","27/2914",0.436615793015887,0.506786188322011,0.290324881164229,"CDK2",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/61","27/2914",0.436615793015887,0.506786188322011,0.290324881164229,"SRC",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/61","28/2914",0.448519650524037,0.517140173553214,0.296256415213683,"CDK1",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/61","28/2914",0.448519650524037,0.517140173553214,0.296256415213683,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/61","28/2914",0.448519650524037,0.517140173553214,0.296256415213683,"EP300",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/61","29/2914",0.460176026587112,0.5282373815128,0.302613722607535,"CDK1",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/61","29/2914",0.460176026587112,0.5282373815128,0.302613722607535,"SRC",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/61","30/2914",0.471589982350782,0.537778050049137,0.308079328267016,"CREB1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/61","30/2914",0.471589982350782,0.537778050049137,0.308079328267016,"CDK1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/61","30/2914",0.471589982350782,0.537778050049137,0.308079328267016,"UBE2I",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/61","31/2914",0.482766477176233,0.54811914439223,0.314003477455468,"AKT1",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/61","31/2914",0.482766477176233,0.54811914439223,0.314003477455468,"AKT1",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","4/61","171/2914",0.485388710328988,0.549895706690793,0.315021224683187,"SRC/DUSP1/MAPK1/MAPK3",4
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/61","32/2914",0.49371037065256,0.556896730454081,0.319031932628552,"EP300",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/61","32/2914",0.49371037065256,0.556896730454081,0.319031932628552,"SRC",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","3/61","126/2914",0.496079031354358,0.558357351307935,0.319868685061024,"CTNNB1/SRC/TAF1",3
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/61","33/2914",0.504426424570046,0.564089765110589,0.3231526387172,"CASP1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/61","33/2914",0.504426424570046,0.564089765110589,0.3231526387172,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/61","33/2914",0.504426424570046,0.564089765110589,0.3231526387172,"CDK2",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/61","34/2914",0.514919304855095,0.572132560950106,0.327760151313522,"CDK1",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/61","34/2914",0.514919304855095,0.572132560950106,0.327760151313522,"SRC",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/61","34/2914",0.514919304855095,0.572132560950106,0.327760151313522,"TP53",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/61","35/2914",0.525193583467539,0.580671375462917,0.332651820356287,"SRC",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/61","35/2914",0.525193583467539,0.580671375462917,0.332651820356287,"CTNNB1",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","5/61","228/2914",0.525954265082758,0.580671375462917,0.332651820356287,"CTNNB1/SRC/AR/MAPK1/MAPK3",5
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","1/61","36/2914",0.535253740261037,0.589686324016396,0.33781625444664,"SRC",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/61","37/2914",0.545104164807276,0.599268849259585,0.343305838745876,"CDK1",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/61","87/2914",0.549620905297751,0.602570340148916,0.345197178668306,"MAPK1/MAPK3",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/61","428/2914",0.550424829943721,0.602570340148916,0.345197178668306,"CREB1/CREBBP/CTNNB1/SRC/CASP1/EP300/MAPK1/MAPK3/ATF1",9
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/61","38/2914",0.554749158184668,0.604757992151001,0.346450428701889,"UBE2I",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/61","38/2914",0.554749158184668,0.604757992151001,0.346450428701889,"GSK3B",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/61","39/2914",0.564192934732212,0.613766372512029,0.351611100042316,"EP300",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/61","42/2914",0.591357841574419,0.636658545794406,0.36472544222635,"AKT2",1
"R-HSA-162599","R-HSA-162599","Late Phase of HIV Life Cycle","1/61","42/2914",0.591357841574419,0.636658545794406,0.36472544222635,"TAF1",1
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","1/61","42/2914",0.591357841574419,0.636658545794406,0.36472544222635,"SRC",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/61","42/2914",0.591357841574419,0.636658545794406,0.36472544222635,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/61","42/2914",0.591357841574419,0.636658545794406,0.36472544222635,"STAT1",1
"R-HSA-109582","R-HSA-109582","Hemostasis","6/61","298/2914",0.60406873083168,0.648999462877011,0.371795238854644,"AKT1/CDK2/SRC/TP53/MAPK1/MAPK3",6
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/61","44/2914",0.608535209019233,0.651020508093712,0.372953044110365,"SRC",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/61","44/2914",0.608535209019233,0.651020508093712,0.372953044110365,"CDK2",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/61","97/2914",0.609705745080072,0.651020508093712,0.372953044110365,"MAPK3/STAT1",2
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/61","45/2914",0.616855540813598,0.657305084473506,0.376553317623486,"STAT5A",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/61","46/2914",0.625001867760398,0.662298587460118,0.379413968119865,"AKT2",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/61","46/2914",0.625001867760398,0.662298587460118,0.379413968119865,"UBE2I",1
"R-HSA-422475","R-HSA-422475","Axon guidance","5/61","254/2914",0.625362704697919,0.662298587460118,0.379413968119865,"CREB1/GSK3B/SRC/MAPK1/MAPK3",5
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/61","47/2914",0.632977769457266,0.667643894762227,0.382476158335446,"SRC",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/61","47/2914",0.632977769457266,0.667643894762227,0.382476158335446,"STAT1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/61","48/2914",0.640786753085835,0.6745123716693,0.386410933567635,"CASP1",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/61","50/2914",0.655917641397886,0.68904479500384,0.394736188230945,"AKT2",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/61","51/2914",0.663246211186548,0.69254624461246,0.396742079403494,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/61","51/2914",0.663246211186548,0.69254624461246,0.396742079403494,"AKT2",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/61","51/2914",0.663246211186548,0.69254624461246,0.396742079403494,"CDK2",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/61","53/2914",0.677445761565843,0.703137317393689,0.402809434863186,"TAF1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/61","53/2914",0.677445761565843,0.703137317393689,0.402809434863186,"SRC",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/61","53/2914",0.677445761565843,0.703137317393689,0.402809434863186,"SRC",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/61","165/2914",0.681407434987297,0.705840370903176,0.404357945274492,"CREB1/MAPK1/MAPK3",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","1/61","56/2914",0.697647651249976,0.721226200099378,0.413172094388915,"CDK1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/61","61/2914",0.728586540613716,0.75171627206177,0.430639078934172,"SRC",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/61","64/2914",0.745632088574248,0.767779576353682,0.439841336251198,"SRC",1
"R-HSA-373080","R-HSA-373080","Class B/2 (Secretin family receptors)","1/61","65/2914",0.751076454397747,0.771857225863297,0.442177317650431,"SMO",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/61","296/2914",0.757887739003136,0.777320757951934,0.445307235830764,"AKT1/AKT2/AKT3/FBXW7/SRC",5
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/61","68/2914",0.766731053917018,0.78484281109616,0.449616428219055,"SRC",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/61","69/2914",0.771730845101509,0.788408721911169,0.451659247572593,"SRC",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/61","72/2914",0.786106261426803,0.801520109690073,0.459170427211115,"SRC",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/61","73/2914",0.790697224851491,0.804623399066097,0.460948222541914,"SRC",1
"R-HSA-162906","R-HSA-162906","HIV Infection","1/61","80/2914",0.820229107906943,0.833045187717989,0.47723034033237,"TAF1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","8/61","486/2914",0.822210035157588,0.833429275403403,0.477450374370776,"AKT1/AKT2/AKT3/CREB1/SMO/SRC/MAPK1/MAPK3",8
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","7/61","436/2914",0.829120817437544,0.838799270559383,0.480526707628149,"AKT1/AKT2/AKT3/CREB1/SRC/MAPK1/MAPK3",7
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","3/61","217/2914",0.84467180642921,0.852872503579008,0.488588903872185,"CREB1/SRC/MAPK1",3
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/61","88/2914",0.848983289886741,0.855564555699816,0.490131111868518,"FBXW7",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/61","109/2914",0.904656285422948,0.909905741624628,0.521261791254595,"AKT1",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/61","115/2914",0.916449737267933,0.91998815324194,0.527037747707427,"FBXW7",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","1/61","125/2914",0.932996520055336,0.934794201211512,0.535519754945057,"MAPK1",1
"R-HSA-500792","R-HSA-500792","GPCR ligand binding","1/61","317/2914",0.999177496226255,0.999177496226255,0.572403302493988,"SMO",1
